The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Active, not recruiting	Phase 2	2026-07-20		NCT03414658

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Adrienne G. Waks	3
Breast Cancer Research Foundation	40
Johns Hopkins University	579
Pfizer	431

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baylor College of Medicine	Houston	United States	306
Beth Israel Deaconess Medical Center	Boston	United States	45
Dana-Farber Cancer Institute	Boston	United States	626
Duke University Medical Center	Durham	United States	505
Georgetown University Medical Center	Washington D.C.	United States	62
Indiana University Health Melvin and Bren Simon Cancer Center	Indianapolis	United States	5
Johns Hopkins University	Baltimore	United States	150
MD Anderson Cancer Center	Houston	United States	589
Memorial Sloan-Kettering Cancer Center	New York	United States	63
Montefiore Medical Center	The Bronx	United States	198
University of Alabama at Birmingham	Birmingham	United States	35
University of California San Francisco	San Francisco	United States	80
University of Carolina at Chapel Hill	Chapel Hill	United States	1
University of Chicago Medical Center	Chicago	United States	152
University of Pennsylvania	Philadelphia	United States	507
University of Washington Fred Hutchinson Cancer Care	Seattle	United States	3
Vanderbilt University Medical Center	Nashville	United States	427